216 related articles for article (PubMed ID: 30468798)
1. The high efficacy of muscarinic M4 receptor in D1 medium spiny neurons reverses striatal hyperdopaminergia.
Nair AG; Castro LRV; El Khoury M; Gorgievski V; Giros B; Tzavara ET; Hellgren-Kotaleski J; Vincent P
Neuropharmacology; 2019 Mar; 146():74-83. PubMed ID: 30468798
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic acetylcholine M
Liu L; Huang Y; Huang Q; Zhao Z; Yu J; Wang L
Neuropharmacology; 2017 May; 117():376-386. PubMed ID: 28257887
[TBL] [Abstract][Full Text] [Related]
3. Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice.
Zhang W; Yamada M; Gomeza J; Basile AS; Wess J
J Neurosci; 2002 Aug; 22(15):6347-52. PubMed ID: 12151512
[TBL] [Abstract][Full Text] [Related]
4. Detection of phasic dopamine by D1 and D2 striatal medium spiny neurons.
Yapo C; Nair AG; Clement L; Castro LR; Hellgren Kotaleski J; Vincent P
J Physiol; 2017 Dec; 595(24):7451-7475. PubMed ID: 28782235
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons.
Kuroiwa M; Hamada M; Hieda E; Shuto T; Sotogaku N; Flajolet M; Snyder GL; Hendrick JP; Fienberg A; Nishi A
Neuropharmacology; 2012 Dec; 63(7):1248-57. PubMed ID: 22971543
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release.
Foster DJ; Wilson JM; Remke DH; Mahmood MS; Uddin MJ; Wess J; Patel S; Marnett LJ; Niswender CM; Jones CK; Xiang Z; Lindsley CW; Rook JM; Conn PJ
Neuron; 2016 Sep; 91(6):1244-1252. PubMed ID: 27618677
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice.
Gomeza J; Zhang L; Kostenis E; Felder C; Bymaster F; Brodkin J; Shannon H; Xia B; Deng C; Wess J
Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10483-8. PubMed ID: 10468635
[TBL] [Abstract][Full Text] [Related]
8. M1 muscarinic receptors contribute to, whereas M4 receptors inhibit, dopamine D1 receptor-induced [3H]-cyclic AMP accumulation in rat striatal slices.
Sánchez-Lemus E; Arias-Montaño JA
Neurochem Res; 2006 Apr; 31(4):555-61. PubMed ID: 16758365
[TBL] [Abstract][Full Text] [Related]
9. Generation and pharmacological analysis of M2 and M4 muscarinic receptor knockout mice.
Gomeza J; Zhang L; Kostenis E; Felder CC; Bymaster FP; Brodkin J; Shannon H; Xia B; Duttaroy A; Deng CX; Wess J
Life Sci; 2001 Apr; 68(22-23):2457-66. PubMed ID: 11392613
[TBL] [Abstract][Full Text] [Related]
10. An allosteric enhancer of M₄ muscarinic acetylcholine receptor function inhibits behavioral and neurochemical effects of cocaine.
Dencker D; Weikop P; Sørensen G; Woldbye DP; Wörtwein G; Wess J; Fink-Jensen A
Psychopharmacology (Berl); 2012 Nov; 224(2):277-87. PubMed ID: 22648127
[TBL] [Abstract][Full Text] [Related]
11. Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.
Ztaou S; Maurice N; Camon J; Guiraudie-Capraz G; Kerkerian-Le Goff L; Beurrier C; Liberge M; Amalric M
J Neurosci; 2016 Aug; 36(35):9161-72. PubMed ID: 27581457
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
Wei W; Ding S; Zhou FM
J Neurophysiol; 2017 Mar; 117(3):987-999. PubMed ID: 27927785
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic and cholinergic regulation of Fyn tyrosine kinase phosphorylation in the rat striatum in vivo.
Mao LM; Wang JQ
Neuropharmacology; 2015 Dec; 99():491-9. PubMed ID: 26277342
[TBL] [Abstract][Full Text] [Related]
14. Cholinergic Projections to the Substantia Nigra Pars Reticulata Inhibit Dopamine Modulation of Basal Ganglia through the M
Moehle MS; Pancani T; Byun N; Yohn SE; Wilson GH; Dickerson JW; Remke DH; Xiang Z; Niswender CM; Wess J; Jones CK; Lindsley CW; Rook JM; Conn PJ
Neuron; 2017 Dec; 96(6):1358-1372.e4. PubMed ID: 29268098
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Phosphorylation of AMPA Glutamate Receptors by Muscarinic M4 Receptors in the Striatum In vivo.
Mao LM; He N; Jin DZ; Wang JQ
Neuroscience; 2018 Apr; 375():84-93. PubMed ID: 29432883
[TBL] [Abstract][Full Text] [Related]
16. Integrated regulation of AMPA glutamate receptor phosphorylation in the striatum by dopamine and acetylcholine.
Xue B; Chen EC; He N; Jin DZ; Mao LM; Wang JQ
Neuropharmacology; 2017 Jan; 112(Pt A):57-65. PubMed ID: 27060412
[TBL] [Abstract][Full Text] [Related]
17. Modulation of direct pathway striatal projection neurons by muscarinic M₄-type receptors.
Hernández-Flores T; Hernández-González O; Pérez-Ramírez MB; Lara-González E; Arias-García MA; Duhne M; Pérez-Burgos A; Prieto GA; Figueroa A; Galarraga E; Bargas J
Neuropharmacology; 2015 Feb; 89():232-44. PubMed ID: 25290553
[TBL] [Abstract][Full Text] [Related]
18. A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors.
Jeon J; Dencker D; Wörtwein G; Woldbye DP; Cui Y; Davis AA; Levey AI; Schütz G; Sager TN; Mørk A; Li C; Deng CX; Fink-Jensen A; Wess J
J Neurosci; 2010 Feb; 30(6):2396-405. PubMed ID: 20147565
[TBL] [Abstract][Full Text] [Related]
19. Differential dopaminergic regulation of inwardly rectifying potassium channel mediated subthreshold dynamics in striatal medium spiny neurons.
Zhao B; Zhu J; Dai D; Xing J; He J; Fu Z; Zhang L; Li Z; Wang W
Neuropharmacology; 2016 Aug; 107():396-410. PubMed ID: 27018450
[TBL] [Abstract][Full Text] [Related]
20. Selective Vulnerability of Striatal D2 versus D1 Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic Male Mice.
Schier CJ; Marks WD; Paris JJ; Barbour AJ; McLane VD; Maragos WF; McQuiston AR; Knapp PE; Hauser KF
J Neurosci; 2017 Jun; 37(23):5758-5769. PubMed ID: 28473642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
